The global population health management market was valued at approximately $70.1 billion in 2023, with projections pointing to remarkable growth, reaching around $663.75 billion by 2034. This expansion corresponds to a robust compound annual growth rate (CAGR) of 22.05% from 2024 to 2034.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5230
The population health management (PHM) market is designed to improve clinical health outcomes for specific groups by offering financial resources and care models that enhance care coordination and patient engagement. PHM focuses on multiple aspects, including care coordination, return on investment (ROI), healthcare quality, resource management, healthcare reform, health economics, and compliance programs. It also relies on clinical case studies and evidence-based approaches to manage public health conditions. By leveraging healthcare data and advanced technologies, PHM aims to create more efficient and effective health systems through data aggregation, analytics, and governance.
Artificial intelligence (AI) plays a pivotal role in enhancing PHM processes. By leveraging AI tools, healthcare systems can:
For example, in February 2024, Persistent Systems, in collaboration with Microsoft, introduced an innovative PHM solution powered by generative AI. This solution aligns with value-based care models and incorporates Social Determinants of Health (SDoH) to address patients’ non-clinical needs. It also provides more accurate predictions of care costs related to clinical conditions.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/population-health-management-market-sizing
Access exclusive insight now @ https://www.towardshealthcare.com/price/5230
We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com
Web: https://www.towardshealthcare.com
Visit Dental Specifics: https://www.towardsdental.com
Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
Kedrion Biopharma has announced that its human coagulation factor X concentrate, COAGADEX®, has been granted orphan drug designation by the… Read More
enecard PBF, a pioneer in pharmacy benefit facilitation, has announced a strategic partnership with DecisionRX, Inc., a leader in medication… Read More
In a high-stakes biotech industry where drug development can span over a decade, four small but determined biotech companies are… Read More
cell-free DNA and precision medicine, has officially announced the launch of the TEODOR trial (ABCSG 61), a groundbreaking phase 2,… Read More
The global interventional radiology market is witnessing rapid expansion, driven by advancements in minimally invasive procedures, rising demand for diagnostic… Read More
The global physical therapy market is valued at USD 28.06 billion in 2024, growing to USD 29.18 billion in 2025… Read More